Compare ResMed Inc. (RMD) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs United Parcel Service Inc — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.89B), while United Parcel Service Inc trades at $99.5 (market cap $85.49B). The key difference: United Parcel Service Inc is far larger — about 2.7× ResMed Inc.'s market cap, and United Parcel Service Inc pays the higher dividend (6.53%). Which is the better fit depends on your goals.
| RMD | UPS | |
|---|---|---|
Market Cap | $31.89B | $85.49B |
Sector | Health | Industrials |
52-Week High | $283.28 | $120.00 |
52-Week Low | $182.82 | $82.58 |
Enterprise Value | $31.24B | $109.51B |
Dividend Yield | 1.19% | 6.53% |
Volume | — | 2,288,643 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
UPS stock trades at $100.48, down 1.78% on the day, with a bearish technical signal from moving averages but neutral oscillators. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 highlight operational strength, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. The company announced a $2B+ global investment to enhance logistics and appointed a new Chief Global Operations Officer, signaling strategic shifts. Valuation metrics include a P/E of 18.68 and P/S of 0.95, with a dividend yield of 6.2% based on the $1.64 per share payout.
The outlook is mixed: analyst consensus leans neutral with a $117.90 price target, but risks include declining net income margins and high dividend payout ratios limiting investment flexibility. Upside potential exists from efficiency gains and global expansion, while macroeconomic pressures and competitive threats pose challenges for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
